VIROMETIX
Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. In an increasingly global world there is a considerable medical need for vaccines to combat infectious as well as a number of chronic human diseases. Fast growing demands, health threats from newly arising complex viral and bacterial pathogens and increasingly stringent requirements for stability, safet... y and tolerability require new approaches to tackling current and future challenges. Rational molecular design, chemical synthesis and Virometix' proprietary Synthetic Virus-Like Particle platform technology allow for the rapid production and optimization of vaccine candidates with superior properties in terms of safety, efficacy and stability.
VIROMETIX
Industry:
Biotechnology Health Care Medical
Founded:
2009-01-01
Address:
Schlieren, Zurich, Switzerland
Country:
Switzerland
Website Url:
http://www.virometix.com
Total Employee:
11+
Status:
Closed
Contact:
+41 (0) 43 433 86 60
Total Funding:
13.71 M CHF
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Maps SSL By Default
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
BioCentrum
BioCentrum is a privately-owned biotechnology service and product provider.
Calimmune
Calimmune is a clinical-stage gene therapy company.
Crioestaminal
Crioestaminal is a privately held biotechnology company that engages in preservation of stem cells to treat future ailments.
Cytovation
Cytovation AS is a privately-held biotech company, specialising .
Genis
Genis is a privately held biotechnology company located in Iceland.
Gubra
Gubra is a privately-held biotech company
Mucosis
Mucosis is a clinical stage Dutch biotechnology company developing mucosal vaccines.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Board_member
2020-07-16
Board_member
Board_member
Current Employees Featured
Anna Sumeray CEO @ Virometix
CEO
2019-02-01
Armando Zuniga Chief Scientific Officer @ Virometix
Chief Scientific Officer
Investors List
Harry Welten
Harry Welten investment in Series A - Virometix
Venture Kick
Venture Kick investment in Grant - Virometix
Official Site Inspections
http://www.virometix.com Semrush global rank: 9.98 M Semrush visits lastest month: 286
- Host name: 104.21.4.27
- IP address: 104.21.4.27
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Virometix"
Home - Virometix AG
Virometix AG is a clinical stage biotech company pioneering a new class of synthetic vaccines to tackle infectious diseases and cancer. Our structure-based vaccines are designed to direct a precise, robust and sustained immune …See details»
About us - Virometix AG
Virometix AG is a privately held Swiss biotechnology company whose purpose is the discovery and development of fully synthetic vaccines to generate targeted and protective immune responses against infectious diseases and cancer. ...See details»
Virometix - Crunchbase Company Profile & Funding
Virometix is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. In an increasingly global world there …See details»
About us - Virometix AG
Virometix. About us. About us. Contact Us. Interested in learning more about our company, our technology, or our pipeline? Please contact us here. VIROMETIX AG. Wagistrasse 14 8952 …See details»
Virometix Company Profile 2024: Valuation, Funding & Investors
Virometix General Information Description. Developer of vaccines and immunotherapeutic drugs designed to prevent and treat infections and chronic human diseases. The company's …See details»
Virometix AG – Swiss Biotech
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic …See details»
Virometix AG - LinkedIn
Virometix AG | 799 followers on LinkedIn. Developing a new generation of vaccines and immunotherapeutic drugs | Virometix is a privately held Swiss biotechnology company …See details»
Virometix Company Profile: Overview and Full News Analysis
Virometix AG, located in Zurich, is a clinical stage biotech company at the forefront of developing a new class of synthetic vaccines to combat infectious diseases and cancer. Their innovative …See details»
Virometix AG - LinkedIn
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic …See details»
Virometix - VentureRadar
" Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and …See details»
Virometix AG (Virometix AG) - 药物管线_专利_临床试验_投融营收_ …
Jan. 7, 2021 14:00 UTC SCHLIEREN, Switzerland--(BUSINESS WIRE)-- Virometix, a privately held Swiss biotechnology company developing a new generation of vaccines and …See details»
Virometix - Funding, Financials, Valuation & Investors - Crunchbase
Virometix is a privately held biotechnology company developingSee details»
Virometix AG Overview | SignalHire Company Profile
Virometix is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and …See details»
Virometix Company Profile - Office Locations, Competitors ... - Craft
Virometix has 5 employees at their 1 location and $18.53 m in total funding,. See insights on Virometix including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Virometix - Overview, News & Similar companies | ZoomInfo.com
Virometix AG is a privately held Swiss biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infections and …See details»
Virometix - Products, Competitors, Financials, Employees, …
About Virometix. Virometix is a clinical stage biotech company focused on developing synthetic vaccines for infectious diseases and cancer. The company offers a proprietary modular and …See details»
Collaborations - Virometix AG
Virometix is offering co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses and other selected infectious diseases and chronic human …See details»
Pipeline - Virometix AG
Virometix is currently evaluating several options to provide best-in-class therapeutic solutions for cancer. Contact Us. Interested in learning more about our company, our technology, or our …See details»
Virometix AG - startup.ch
Virometix AG: A new platform technology called Synthetic Virus-Like Particle (SVLP) technology for synthetic vaccine design has been developed. The technology has the potential to …See details»
Newsroom - Virometix AG
Jul 9, 2020 With these results Virometix has achieved one of its main scientific goals in 2022. European & International Peptide Symposium 2022. 28 August 2022 – Virometix attended the …See details»